From 1 November 2023, the shingles vaccine Shingrix® will replace Zostavax® on the National Immunisation Program (NIP) schedule to help prevent shingles and post-herpetic neuralgia.
A free 2-dose course of Shingrix® will be available for:
- people aged 65 years or over
- First Nations people aged 50 years or over, and
- immunocompromised people aged 18 years or over with specific medical conditions such as haemopoetic stem cell transplant, solid organ transplant, haematological malignancy and advanced or untreated HIV